Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q1- Text added to 2020 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
acquisitionof, additi, Afinitor, airway, Alvotech, amplify, analyst, arm, asa, asan, avoid, banc, bellwether, BrandName, budesonide, cal, cerebral, Chicago, chose, closure, companion, constitute, correlating, couldhave, criminal, ctive, dermatological, detriment, digital, discovered, Distric, doctor, dominant, ed, EIB, endedJune, ernment, EU, expert, FACT, fewer, field, fil, formal, Francisco, Genericsresulting, Genericsthat, Goa, gov, hs, Ill, impairm, includematerial, ingredient, inhibiting, introduction, irbesartan, itwith, LaunchDate, losartan, maximum, mcg, milliongain, millionin, mobile, mont, monthly, nineteen, nominally, numerical, obstructive, ofcertain, ofcontract, ofthe, overseeing, palsy, physical, placebo, powder, precipitate, prescription, pro, protectionist, protest, Protracted, Pulmicort, ranitidine, rehearingen, rescue, respectiv, Rituxan, Romidepsin, San, Seco, sha, shift, showed, stake, stand, statistical, stemming, thea, theperiod, threeand, Timeof, ts, upper, vincial, Virgin, water, week, yearperiod
Valuein 2020 Q1 filing- Value in 2020 Q2 filing
Original filings
Filing view